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doi:10.1016/j.ejvs.2009.05.014Abstract Objectives: The aim of this study was to determine accurate estimates of the
success rate of subintimal angioplasty in terms of ability to recanalise occluded vessels,
patency over time and limb salvage rates.
Design: A meta-analysis of published literature.
Materials: All studies reporting unique patient data published in English language between
1989 and 2008.
Methods: Separate meta-analyses were performed for immediate technical success, 12-month
patency rates and 12-month limb salvage rates. Longer-term outcomes were analyzed in sepa-
rate meta-analyses. Meta-regression was applied to determine whether any of these outcomes
had improved over time.
Results: Pooled estimates for technical success, primary patency at 12 months and limb
salvage at 12 months were 85.7% (95% confidence interval: 83.3%e87.7%, 2810 limbs), 55.8%
(95% confidence interval: 47.9%e63.4%, 1342 limbs), and 89.3% (95% confidence interval:
85.5%e92.2%, 2810 limbs), respectively. Regression analysis demonstrated no significant
change in outcomes over time. There was some evidence of publication bias, however, after
adjusting for this there was little change in the pooled outcome estimates.
Conclusions: This study demonstrates that the outcomes for subintimal angioplasty are good
and that this method should be considered as an alternative to surgical bypass.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.523252; fax:þ441162523179.
(M.J. Bown).
ty for Vascular Surgery. PublisheIntroduction
Infra-inguinal bypass surgery for occlusive peripheral
vascular disease is associated with high hospital costs,
significant morbidity and mortality rates and less than ideal
long-term outcomes in terms of both limb salvage andd by Elsevier Ltd. All rights reserved.
324 M.J. Bown et al.mortality. Unfortunately there are few alternatives other
thanmajor lower limb amputation in those patientswith long
occlusions who are unsuitable for transluminal angioplasty.
Nearly two decades ago subintimal angioplasty (SIA) for
peripheral vascular disease was first described by Bolia
et al.1 with the potential to reduce the need for surgery.
Since the time of this first report, vascular interventional
radiology has been polarised into those who can reproduce
these results and are proponents of SIA and those who
cannot. The published literature reflects these polarised
viewpoints with some authors supporting the technique and
others dismissing it. The majority of these reports feature
small series of patients and, to date, there remains little
long-term follow-up data in the literature. Presently
the only randomised trial of angioplasty vs infra-inguinal
bypass surgery was not powered to examine the subgroups
of participating centres that utilised SIA (reported as 50%).2
Since the literature regarding SIA is often viewed as
conflicting we set out to systematically review and
combine, using meta-analytical techniques, the reported
outcomes of SIA and to determine whether there had been
any trends in outcomes over the last 19 years since the
technique was first described. In addition, we wished to
determine whether there was any potential explanation for
the variability in the success of SIA amongst different
institutions through the assessment of between study
heterogeneity and publication bias.
Methods
Literature search
A systematic reviewandmeta-analysis of the English language
literature regarding outcomes following SIAwas performed. A
literature search was performed by MJB. Both Medline (1950
to 11/8/08) and EMBASE (1950 to 11/8/08) databases were
searched using the Ovid search engine (Ovid version Ovid-
SP_UI02.00.02.101). The following keyword combinations
were used for both databases and the results combined:
search ‘‘subintimal AND angioplasty’’, ‘‘percutaneous AND
extraluminal’’, ‘‘revascularization AND extraluminal’’,
‘‘intentional AND extraluminal’’, ‘‘percutaneous AND inten-
tional’’, and ‘‘revascularization AND intentional’’. The liter-
ature search was performed for a period prior to the first
description of SIA toensure that noearlier references existed.
The reference lists from the studies retrieved were hand-
searched to ensure other additional relevant articles had not
been missed by the electronic searches. The abstracts or on-
line versions of the articles identified by the literature search
were examined for relevance. Where articles had no elec-
tronically available abstract, or, if this were ambiguous, the
full version of thearticlewasobtained.Retainedarticleswere
obtained from local library collections or the British Library.
Where articles were not available from these sources, indi-
vidual authors were contacted to obtain reprints directly.
Study selection
Studies were included in the analysis if they gave details of
patients undergoing SIA and their outcomes (immediate
technical success, primary patency, and limb salvage).Articles were rejected if they contained no primary data,
contained data previously or subsequently reported in
other articles, were reports of small cases series (less than
10 patients) or highly selected subgroups of patients. In the
case of overlapping articles from the same centre, these
were excluded if they overlapped by more than 6 months. If
different outcomes from the same time period were
reported in different articles these articles were included
or, if one or more overlapping outcomes could be excluded,
the articles were retained and only the overlapping
outcomes excluded. Where an article was rejected due to
excessive overlap with another article the study with the
longest overall time period covered was retained. Articles
in languages other than English were also excluded.
Unpublished data or conference abstracts were not
included in the review.Data extraction
The three principle outcome measures assessed in this
study were immediate technical success rate of SIA, 12-
month primary patency rate, and 12-month limb salvage
rate. All studies that gave details of patients undergoing
SIA with immediate technical success rates were included
in the analysis (those that just reported outcomes in
patients with successful SIA and where no details of those
patients with failed SIA were given were excluded). For
each study the total number of limbs treated and
outcomes were recorded on a per-limb basis. The location
of the lesions treated in each study was also recorded. In
addition to technical success rate, the primary patency
and limb salvage rates were recorded at both 12 months
after SIA (where given) and at the longest quoted follow-
up after SIA for each individual study. For both primary
patency and limb salvage rates, data were recorded on an
intention-to-treat basis with the numerator being the
number of limbs saved or patent at each time point and
the denominator being the number of limbs that under-
went attempted SIA at the outset of the study. As
a temporal reference point for each study the mid-date of
the study was calculated (the date mid-way from the
reported start of the study to the end of the study).
Where only an overall length of time for the study was
quoted the manuscript acceptance date was used as the
end date of the study and the mid-date back-calculated
from this.
Data pertaining to potential quality indicators (retro-
spective or prospective, randomization, study size) was also
extracted for the purposes of performing sensitivity anal-
yses. Three covariates that were of interest were also
extracted from each study for the purposes of determining
whether these had any effect on patient outcome e the
degree of limb ischaemia in patients undergoing SIA, the use
of adjunctive stents and patient selection criteria for SIA.
All figures quoted as percentages were converted back
to numerators and denominators prior to analysis and all
data were extracted by a single author (MJB) but in dupli-
cate with a minimum two-month interval between extrac-
tions. Discrepancy between the data extracted at the two
time points was resolved by consensus between the
authors.
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Meta-analyses were performed for the three primary
outcome measures of immediate technical success rate,
12-month primary patency rate and 12-month limb salvage
rate. In addition, where individual studies quoted rates for
primary patency and limb salvage at other time periods
instead of, or in addition to, rates at 12 months these were
recorded and then separate meta-analyses were performed
for each group of studies reporting the outcomes at each
time point (6, 9, 10, 12, 13, 14, 24, 36, 48 and 60 months) to
determine how patency and limb salvage rates changed
over longer follow-up periods. Where a study quoted
outcomes at multiple time points the data for each sepa-
rate time point was combined in the analyses for each time
point leading to several studies contributing to multiple
analyses. All data extracted consisted of rates in the form
of proportions. These were converted to a log odds scale for
subsequent meta-analysis. Meta-analyses were performed555 studies identified by literature
search
150 studies retrieved
37 studies inclu
36 rep
technical
ra
19 reported 12 month
primary patency rate
 
25 reported primary
patency rate after any
period of follow up
Figure 1 Studyusing random effects models in all cases since it was
perceived that the outcome measures being explored were
unlikely to be fixed across all populations. The presence of
between-studies heterogeneity was determined using the
standard Chi-squared test and quantified using I2.3
Weighted random effects linear regression analysis was
performed for each of the 3 primary outcome measures
with the covariate mid-date of study to determine whether
there had been any change in these outcome measures over
time. Each study included in the regression analysis was
weighted by the inverse of its variance as in the prior meta-
analyses.
To investigate the possibility of publication bias in the
literature, funnel plots were constructed and examined
visually for asymmetry. Where asymmetry was identified,
among the less precise studies towards the bottom of the
funnel plots the primary meta-analyses were repeated
using only the more precise studies towards the top of the
plot for which asymmetry was not evident.405 studies rejected on
basis of abstract/article
examined electronically
112 studies rejected:
28 different subject area (no data) 
24 small cases series (<10)/case report 
16 no data reported
15 systematic reviews
8 letter/comment/editorial (no data)
7 data reported in another paper
(overlap)
6 foreign language
6 reports of technical variations
2 highly selected sub-groups of patients
1 unobtainable (British/local libraries)
ded in analysis
orted
 success
te
 
18 reported 12 month
limb salvage rate
 
23 reported limb
salvage rate after any
period of follow-up
flow diagram.
Table 1 Summary data for all 38 studies included in the meta-analysis
First author Mid-date
of study
Retrospective
or prospective
Study type Selection
criteria
Disease
severity
Lesion
location
n
SIA
Technical
success
12-Month follow-up
data provided or
extractable
Maximum length
of follow-up data
provided (months)
Stents
used?
n % Primary
patency
Limb
salvage
Primary
patency
Limb
salvage
Aarts 20065 01/11/2003 Retrospective Case note review Unfit for
surgery
Not stated Infra-
inguinal
39 26 67 No Yes 12 Yes
Akesson 20076 01/07/2000 Retrospective Case note review Unless
very fit
CLI Infra-
inguinal
193 148 77 No No 36 36 Yes
Antusevas
20087
01/07/2004 Retrospective-
Prospective
Case note review Not stated Claudication
and CLI
SFA 73 64 88 Yes Yes 24 13 Yes
Berengoltz-
Zlochin 19948
30/10/1988 Retrospective Case note review Unless
very fit
Claudication Femoro-
popliteal
20 17 85 No No No
Cho 20079 01/05/2004 Retrospective Case note review Not stated Not stated Iliac 40 32 80 Yes No Yes
Desgranges
200410
19/01/2001 Retrospective Case note review Not stated Claudication
and CLI
Infra-
inguinal
100 88 88 No No 24 24 No
Florenes 200411 18/07/1998 Prospective Cohort Not stated Claudication Infra-
inguinal
116 101 87 No No 60 No
Hynes 200512 01/08/2002 Retrospective Case note/
database review
Not stated CLI All 158 No Yes 12 No
Ingle 200213 01/12/1999 Retrospective Case note review Not stated Claudication
and CLI
Ilio-
femoral
70 60 86 No Yes 18 12 No
Kidd 200614 16/11/2002 Retrospective Case note review Not stated Claudication
and CLI
Tibial 43 42 98 Yes No No
Kim 200615 29/02/2004 Retrospective Case note review Unfit for
surgery
Claudication
and CLI
Femoro-
popliteal
30 27 90 Yes Yes 12 All
Ko 200716 15/01/2004 Retrospective Case note review Not stated Claudication
and CLI
All 61 58 95 Yes No All
Kocher 200417 15/11/2002 Retrospective Case note review Not stated Not stated Femoro-
popliteal
24 23 96 No No No
Laxdal 200319 01/04/2001 Prospective Registry review not stated Claudication
and CLI
Femoro-
popliteal
104 88 85 No No 12 No
Laxdal 200418 03/07/1999 Retrospective Case note review Not stated claudication
and cli
Femoro-
popliteal
124 112 90 No Yes 18 12 No
Lazaris 200421 31/08/2004 Prospective Case note review All patients CLI Femoro-
popliteal
51 49 96 Yes Yes 12 No
Lazaris 200620 31/08/2001 Retrospective Case note review Diabetics
with CLI
CLI Infra-
inguinal
112 100 89 No Yes 36 No
Lipsitz 200322 30/09/2000 Retrospective Case note review All patients Claudication
and CLI
Infra-
inguinal
39 34 87 Yes Yes 12 Yes
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London 199423 16/08/1989 Retrospective Case note review All patients Claudication
and CLI
All 200 159 0 Yes No No
Marks 200824 17/03/2005 Prospective Cohort Not stated Not stated Femoro-
popliteal
116 99 5 Yes No Yes
McCarthy 20002502/03/1998 Retrospective Case note review Unfit for
surgery
Claudication
and CLI
Femoro-
popliteal
69 51 4 No No 6 No
Myers 200626 15/03/2005 Retrospective Case note review Not stated CLI Femoro-
popliteal
82 75 1 No No Yes
Nydahl 199727 14/10/1992 Retrospective Case note review Not stated CLI SFA 32 27 4 Yes Yes 12 No
Ostri 200628 30/06/2001 Retrospective Case note review Not stated Not stated Tibial 28 25 9 No No No
Scott 200729 01/06/2003 Retrospective Case note review Not stated Claudication
and CLI
Femoro-
popliteal
105 91 7 Yes No 36 6 Yes
Shaw 200230 16/09/2001 Prospective Cohort Not stated Claudication
and CLI
All 50 39 8 No No 6 No
Smith 200531 17/04/1998 Retrospective Case note review Suitable
patients
Claudication
and CLI
Infra-
inguinal
48 44 2 Yes No No
Spinosa 200432 01/11/2001 Retrospective Case note review Unfit for
surgery
CLI SFA 50 38 6 No No 12 No
Tartari 200434 15/04/2004 Retrospective Case note review All patients CLI Infra-
inguinal
109 92 4 No Yes 9 Yes
Tartari 200733 01/11/2002 Retrospective Case note review Not stated CLI Tibial 20 17 5 No Yes 9 No
Tisi 200235 02/07/1999 Retrospective Case note review All patients Claudication
and CLI
Popliteo-
tibial
158 135 5 Yes Yes 24 No
Treiman 200636 01/07/2001 Retrospective Case note review Not stated CLI Femoro-
popliteal
29 26 0 Yes Yes 48 All
Trocciola 20053702/03/2003 Prospective Registry review All patients Claudication
and CLI
Femoro-
popliteal
121 121 0 Yes Yes 12 12 Yes
Vraux 200039 15/11/2002 Retrospective Case note review Not stated CLI Infra-
inguinal
50 41 2 Yes Yes 24 No
Vraux 200638 01/12/1998 Retrospective Case note review Not stated CLI Popliteo-
tibial
40 31 8 Yes Yes 12 No
Yilmaz 200341 30/09/2000 Retrospective Case note review Unfit for
surgery
Claudication
and CLI
Tibial 67 59 8 Yes Yes 12 12 Yes
Yilmaz 200440 31/08/1997 Retrospective Case note review Not stated Claudication
and CLI
SFA 39 37 5 Yes No 36 Yes
SFAZ Superficial femoral artery.
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328 M.J. Bown et al.Meta-analyses were performed using Review Manager
Version 5 and regression analysis with Prism Version 5.0.16.
All results were converted back to percentages for ease of
interpretation. MOOSE statement guidelines were used in
the design, conduct and reporting of this study.4
Results
Literature search
A total of 556 articles were identified by the literature
search, of which 37 were relevant to the meta-analysis and
were included in the study.5e41 The study flow diagram
(Fig. 1) gives details of the reasons for rejecting those
studies not included in the analysis. One article identified
was unavailable from any source and, therefore, could not
be included.42
Study characteristics
The 37 studies included in the analysis gave details of 2810
limbs treated by SIA over a period of 16.4 years (study mid-Figure 2 Forest plot of technical success rate (plottedates October 1988eMarch 2005) and the characteristics of
these studies are shown in Table 1.
Validity assessment
Quality measures for each individual study were assessed in
order to attempt stratification of the studies according to
such measures and enable a complete sensitivity analysis.
However, since the majority of the studies included in the
analysis (79%) were retrospective case note reviews, (the
remainder were prospective case series) and there were no
randomised trials, the sensitivity analysis was limited to the
exclusion of extreme studies as identified by the
construction of funnel plots.
Meta-analysis
Separate meta-analyses were carried out for the three
principle outcome measures. Immediate procedural tech-
nical success (angiographic re-canalization achieved at the
time of the procedure) was examined in 36 studies giving
details of 2810 limbs undergoing SIA.5e11,13e41 The pooledd on proportional scale for ease of interpretability).
Figure 3 Forest plot of primary patency rate at 12 months (intention-to-treat basis).
Subintimal Angioplasty e Meta-analysis 329estimate for technical success rate in these studies was
85.7% (95% confidence interval: 83.3%e87.7%, I2: 54%)
(Fig. 2). The pooled estimate for 12-month primary patencyFigure 4 Forest plot of limb salvage raterate (19 studies, 1342 limbs7,9,14e16,21e24,27,29,31,35e41) was
55.8% (95% confidence interval: 47.9%e63.4%, I2: 86%)
(Fig. 3). The pooled 12-month limb salvage for the 18 studiesat 12 months (intention-to-treat basis).
Table 2 Primary patency rates: individual meta-analyses performed for each group of studies reporting primary patency rates
at the discreet time points shown following SIA (Random effects models)
Time since
angioplasty
(months)
n
Studies
n
Limbs
Primary
patency (%)
95% Confidence
interval
Test statistics
6 3 139 56.7 48.2e64.8 Heterogeneity: Tau2Z 0.00; Chi2Z 2.01, dfZ 2 (PZ 0.37);
I2Z 0%
Test for overall effect: ZZ 1.55 (PZ 0.12)
10 1 82 84.2 74.6e90.6 n/a
12 11 820 49.5 37.1e61.8 Heterogeneity: Tau2Z 0.64; Chi2Z 108.96, dfZ 10
(P< 0.00001); I2Z 91%
Test for overall effect: ZZ 0.08 (PZ 0.94)
24 4 262 56.3 45.4e66.4 Heterogeneity: Tau2Z 0.13; Chi2Z 8.60, dfZ 3 (PZ 0.04);
I2Z 65%
Test for overall effect: ZZ 1.14 (PZ 0.26)
36 4 392 42.5 33.8e51.7 Heterogeneity: Tau2Z 0.09; Chi2Z 8.11, dfZ 3 (PZ 0.04);
I2Z 63%
Test for overall effect: ZZ 1.62 (PZ 0.11)
48 1 29 10.7 2.9e27.5 n/a
60 1 116 54.3 45.1e63.1 n/a
Note: Individual studies quoting outcomes at more than one time point are included in the analyses for each time point quoted.
330 M.J. Bown et al.that reported this outcome (1322 limbs5,7,12,15,19e22,27,33e39,41)
was 89.3% (95% confidence interval: 85.5%e92.2%, I2: 67%)
(Fig. 4). All three analyses demonstrated moderate to
large heterogeneity between-studies (as indicated by the
I2-values). Studies giving details of either primary
patency or limb salvage rates at follow-up intervalsTable 3 Limb salvage rate: individual meta-analyses performe
discreet time points following SIA (Random effects models)
Time since
angioplasty
(months)
n
Studies
n
Limbs
Limb
salvage
rate (%)
95% Confidence
interval
Test
stat
6 3 224 82.7 66.1e92.1 Hete
I2Z
Test
9 2 129 89.8 83.1e94.0 Hete
I2Z
Test
12 13 925 87.1 79.2e92.3 Hete
I2Z
Test
13 1 73 98.6 91.0e99.8 n/a
24 3 308 82.7 76.9e87.3 Hete
I2Z
Test
36 2 305 79.1 50.3e93.4 Hete
I2Z
Test
48 1 29 34.6 19.4e53.1 n/a
Note: Individual studies quoting outcomes at more than one time poiother than at 12 months were entered into individual
meta-analyses for each time point and the results from
these meta-analyses are summarized in Tables 2 and 3.
These analyses suggest that the figures obtained from
the analyses at 12 months are borne out over the longer
follow-up periods, although limited data are available.d for each group of studies reporting limb salvage rates at
istics
rogeneity: Tau2Z 0.51; Chi2Z 11.71, dfZ 2 (PZ 0.003);
83%
for overall effect: ZZ 3.43 (PZ 0.0006)
rogeneity: Tau2Z 0.00; Chi2Z 0.62, dfZ 1 (PZ 0.43);
0%
for overall effect: ZZ 7.40 (P< 0.00001)
rogeneity: Tau2Z 0.93; Chi2Z 88.39, dfZ 12 (P< 0.00001);
86%
for overall effect: ZZ 6.49 (P< 0.00001)
rogeneity: Tau2Z 0.03; Chi2Z 2.73, dfZ 2 (PZ 0.26);
27%
for overall effect: ZZ 8.46 (P< 0.00001)
rogeneity: Tau2Z 0.86; Chi2Z 16.60, dfZ 1 (P< 0.0001);
94%
for overall effect: ZZ 1.97 (PZ 0.05)
nt are included in the analyses for each time point quoted.
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poorer results at longer follow-up periods than those
seen at 12 months, however, the confidence intervals for
these studies are very wide and there is a high degree of
between-studies heterogeneity.
In order to explore the dataset further to determine
whether there were any systematic differences between
those studies that gave details of follow-up outcomes only
at 12 months and those with later follow-up data presented
the outcomes at 12 months were compared between these
two groups of studies. For the outcome of primary patency
the pooled 12-month primary patency rate in those studies
that only quoted 12-month follow-up (11 studies) was 49.8%
(95% confidence interval: 36.7%e62.6%) compared to
a pooled 12-month primary patency rate of 62.7% (95%
confidence interval: 56.3%e68.8%) in those studies that
gave this data in addition to data at longer periods of follow-
up. Examining the outcome of 12-month limb salvage in
a similar fashion, those studies that gave details of limb
salvage at 12 months alone (14 studies, including one
quoting follow-up at 13 months) demonstrated a 12-monthTable 4a Subgroup analyses for the outcome ‘technical succes
Sub-groups
based on:
Sub-group n
Studies
n
Patients
Technical
success (%)
Technical success rate
Degree of
ischaemia
Claudicants
and CLI
18 1501 87.1
CLI only 11 926 84.4
Not stated 5 247 82.7
Claudicants only 2 136 86.8
Stent usage Stents used
in selected
patients
15 1083 87.1
Stents not used 21 1509 84.9
Stents in all
patientsa
3 120 92.1
Selection
criteria
for SIA
Not stated 21 1346 86.6
Unfit for surgery 5 255 78.8
All patients 6 678 87.1
a This subgroup of studies included in the subgroup ‘‘Stents used inlimb salvage rate of 90.2% (95% confidence interval: 85.5%e
93.9%) compared to a rate of 88.6% (95% confidence
interval: 82.8%e92.6%) in the 4 studies that quoted 12-
month limb salvage rates in addition to longer periods of
follow-up.Regression analyses
Separate regression analyses were performed for the three
main outcome measures using the mid-date of the study as
a covariate to determine whether there had been any
change over time in technical success, 12-month primary
patency or 12-month limb salvage rates. There was little
evidence of association between mid-date of study and
each outcome (PZ 0.16, 0.75 and 0.74 for technical
success rate, 12-month primary patency rate and 12-month
limb salvage rate, respectively) (P-value for testing that the
slope of the regression model, reflecting the change in rate
over time, is significantly different from zero e a significant
result means that there has been a change over time).s rate’
95% Confidence
interval (%)
Model statistics
83.9e89.8 Heterogeneity: Tau2Z 0.16; Chi2Z 39.94,
dfZ 17 (PZ 0.001); I2Z 57%. Test for
overall effect: ZZ 14.46 (P< 0.00001)
79.8e88.1 Heterogeneity: Tau2Z 0.13; Chi2Z 21.05,
dfZ 10 (PZ 0.02); I2Z 53%. Test for
overall effect: ZZ 10.50 (P< 0.00001)
72.1e89.8 Heterogeneity: Tau2Z 0.27; Chi2Z 10.30,
dfZ 4 (PZ 0.04); I2Z 61%. Test for
overall effect: ZZ 4.98 (P< 0.00001)
80.0e91.5 ‘‘Heterogeneity: Tau2Z 0.00; Chi2Z 0.06,
dfZ 1 (PZ 0.80); I2Z 0%. Test for
overall effect: ZZ 7.42 (P< 0.00001)’’
82.6e90.5 Heterogeneity: Tau2Z 0.27; Chi2Z 40.96,
dfZ 14 (PZ 0.0002); I2Z 66%. Test for
overall effect: ZZ 10.71 (P< 0.00001)
82.2e87.3 Heterogeneity: Tau2Z 0.08; Chi2Z 34.82,
dfZ 20 (PZ 0.02); I2Z 43%. Test for
overall effect: ZZ 17.05 (P< 0.00001)
85.4e95.8 Heterogeneity: Tau2Z 0.00; Chi2Z 1.15,
dfZ 2 (PZ 0.56); I2Z 0%. Test for
overall effect: ZZ 7.03 (P< 0.00001)
84.4e88.6 Heterogeneity: Tau2Z 0.02; Chi2Z 23.22,
dfZ 20 (PZ 0.28); I2Z 14%. Test for
overall effect: ZZ 20.41 (P< 0.00001)
69.4e86.0 Heterogeneity: Tau2Z 0.18; Chi2Z 9.71,
dfZ 4 (PZ 0.05); I2Z 59%. Test for
overall effect: ZZ 5.18 (P< 0.00001)
80.5e91.7 Heterogeneity: Tau2Z 0.22; Chi2Z 15.53,
dfZ 5 (PZ 0.008); I2Z 68%. Test for
overall effect: ZZ 7.56 (P< 0.00001)
selected patients’’.
Table 4b Subgroup analyses for the outcome ‘12-month primary patency rate’
Sub-groups
based on:
Sub-group n
Studies
n
Patients
Primary
patency at 12
months (%)
95% Confidence
interval (%)
Model statistics
12-Month primary patency rate
Degree of
ischaemia
Claudicants
and CLI
12 984 56.1 44.8e66.8 Heterogeneity: Tau2Z 0.57; Chi2Z 116.24,
dfZ 11 (P< 0.00001); I2Z 91%. Test for
overall effect: ZZ 1.06 (PZ 0.29)
CLI only 5 263 56.7 44.8e68.1 Heterogeneity: Tau2Z 0.19; Chi2Z 10.84,
dfZ 4 (PZ 0.03); I2Z 63%. Test for overall
effect: ZZ 1.09 (PZ 0.28)
Not stated 2 156 50.0 42.2e57.8 "Heterogeneity: Tau2Z 0.00; Chi2Z 0.00,
dfZ 1 (PZ 1.00); I2Z 0%. Test for overall
effect: ZZ 0.00 (PZ 1.00)"
Claudicants
only
0
Stent usage Stents used
in selected
patients
11 720 61.6 50.7e71.3 Heterogeneity: Tau2Z 0.47; Chi2Z 72.63,
dfZ 10 (P< 0.00001); I2Z 86%. Test for
overall effect: ZZ 2.07 (PZ 0.04)
Stents not
used
8 525 47.9 38.7e57.3 Heterogeneity: Tau2Z 0.22; Chi2Z 32.75,
dfZ 7 (P< 0.0001); I2Z 79%. Test for overall
effect: ZZ 0.43 (PZ 0.67)
Stents in all
patientsa
3 120 69.2 46.5e85.4 Heterogeneity: Tau2Z 0.56; Chi2Z 9.80,
dfZ 2 (PZ 0.007); I2Z 80%. Test for overall
effect: ZZ 1.67 (PZ 0.09)
Selection
criteria for SIA
Not stated 11 628 59.8 52.8e66.56 Heterogeneity: Tau2Z 0.14; Chi2Z 28.00,
dfZ 10 (PZ 0.002); I2Z 64%. Test for overall
effect: ZZ 2.77 (PZ 0.006)
Unfit for
surgery
2 97 32.9 13.8e60.0 Heterogeneity: Tau2Z 0.55; Chi2Z 5.94,
dfZ 1 (PZ 0.01); I2Z 83%. Test for overall
effect: ZZ 1.25 (PZ 0.21)
All patients 4 518 56.9 33.3e77.5 Heterogeneity: Tau2Z 0.91; Chi2Z 70.42,
dfZ 3 (P< 0.00001); I2Z 96%. Test for
overall effect: ZZ 0.56 (PZ 0.57)
a This subgroup of studies included in the subgroup ‘‘Stents used in selected patients’’.
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Subgroup analyses were performed to determine whether
any variation in outcomes between patients with varying
degrees of limb ischaemia (as stated by individual study
authors), between those studies that used adjunctive
stenting and those that did not use adjunctive stenting and
between-studies based on their selection criteria for
patients to undergo SIA (Tables 4ae4c). Differences between
the subgroups were small, especially when the widening of
the confidence intervals as a result of the small study
numbers in each of the subgroups is taken into account.
The effect of anatomical location on the outcomes of SIA
was determined by performing separate meta-analyses for
the different groups of studies that reported on distinct
anatomical locations. Four studies12,15,22,29 made no
distinction in terms of lesion location, 2 reported outcomes
in isolated iliac lesions,9,40 four reported on isolated
superficial femoral artery lesions,7,26,31,41 12 on femoro-
popliteal lesions,8,14,16e19,23e25,28,35,36 2 on combined
popliteal and tibial lesions,34,38 4 on isolated tibiallesions,13,27,33,39 and 9 classified their lesions as ‘‘infra-
inguinal’’.5,6,10,11,20,21,30,32,37 The results of these analyses
are presented in Tables 5ae5c. Differences between the
subgroups were again small. There was a trend towards
poorer technical success rate and 12-month primary
patency in the more distal vessels but limb salvage rates
were similar across all lesion locations.Assessment of publication bias
Funnel plots were constructed for the three main outcome
measures for all the studies that reported each outcome
measure (Fig. 5aec). These demonstrated that for the
outcomes technical success and 12-month limb salvage
rate there was evidence of publication bias with studies
corresponding to poor outcomes (those that should be
occupying the lower left quadrant of the funnel) being
absent in the published literature. There was less evidence
of asymmetry in the funnel plot for 12-month primary
patency rate. When the studies at the lower right quadrant
Table 4c Subgroup analyses for the outcome ‘12-month limb salvage rate’
Sub-groups
based on:
Sub-group n
Studies
n
Patients
Limb salvage
rate at 12
months (%)
95%
Confidence
interval (%)
Model statistics
12-Month limb salvage rate
Degree of
ischaemia
Claudicants
and CLI
8 682 91.0 85.4e94.6 Heterogeneity: Tau2Z 0.39; Chi2Z 23.25,
dfZ 7 (PZ 0.002); I2Z 70%. Test for
overall effect: ZZ 8.32 (P< 0.00001)
CLI only 9 601 89.1 846e92.5 Heterogeneity: Tau2Z 0.17; Chi2Z 15.33,
dfZ 8 (PZ 0.05); I2Z 48%. Test for
overall effect: ZZ 10.21 (P< 0.00001)
Not stated 1 39 69.0 53.1e81.5 n/a
Claudicants only 0
Stent usage Stents used
in selected
patients
8 1227 89.6 79.5e95.1 Heterogeneity: Tau2Z 0.98; Chi2Z 33.51,
dfZ 7 (P< 0.0001); I2Z 79%. Test for
overall effect: ZZ 5.27 (P< 0.00001)
Stents not used 10 764 89.5 86.2e92.1 Heterogeneity: Tau2Z 0.10; Chi2Z 15.98,
dfZ 9 (PZ 0.07); I2Z 44%. Test for
overall effect: ZZ 13.56 (P< 0.00001)
Stents in all
patientsa
2 59 86.1 48.5e97.6 Heterogeneity: Tau2Z 1.45; Chi2Z 4.25,
dfZ 1 (PZ 0.04); I2Z 76%. Test for
overall effect: ZZ 1.89 (PZ 0.06)
Selection criteria
for SIA
Not stated 9 596 91.1 86.3e94.4 Heterogeneity: Tau2Z 0.31; Chi2Z 20.81,
dfZ 8 (PZ 0.008); I2Z 62%. Test for
overall effect: ZZ 9.36 (P< 0.00001)
Unfit for surgery 3 136 83.3 58.3e94.7 Heterogeneity: Tau2Z 1.02; Chi2Z 11.68,
dfZ 2 (PZ 0.003); I2Z 83%. Test for
overall effect: ZZ 2.47 (PZ 0.01)
All patients 5 478 88.9 84.1e92.4 Heterogeneity: Tau2Z 0.08; Chi2Z 6.52,
dfZ 4 (PZ 0.16); I2Z 39%. Test for
overall effect: ZZ 9.90 (P< 0.00001)
a This subgroup of studies included in the subgroup ‘‘Stents used in selected patients’’.
Subintimal Angioplasty e Meta-analysis 333of the funnels for technical success and 12-month limb
salvage rates were excluded from the overall meta-anal-
yses leaving a reasonably symmetrical funnel ‘‘top’’ (indi-
cated by the dotted lines on the figures), the results were
as follows: for immediate technical success 14 studies were
excluded from the analysis and the combined outcome for
technical success in those that remained was 83.5% (95%
confidence interval: 81.0%e85.7%) compared to an
outcome of 85.7% (95% confidence interval: 83.3%e87.7%)
for the analysis as a whole. For 12-month limb salvage rate
the adjusted outcome again remained largely unchanged
(with 7 studies excluded) at 85.7% (95% confidence
interval: 81.2%e89.3%) compared to a value of 89.3% (95%
confidence interval: 85.5%e92.2% for the analysis including
all studies. This suggests that the true rates for each
outcome are marginally lower than the meta-analysis of all
studies together suggests.Discussion
This study demonstrates that the overall technical success
rate for SIA in the published literature is acceptable
(approximately 86%). Whilst actual primary patency overtime does not match this high initial success rate (approx-
imately 56%) long-term limb salvage is excellent at
approximately 90% and this figure is not only maintained at
longer follow-up periods but also is similar irrespective of
the degree of ischaemia in patient groups undergoing SIA,
the use of adjunctive stenting or the selection criteria used
to identify patients for SIA. There appears to have been no
change in technical success, limb salvage or primary
patency rates over the time since SIA was first described
suggesting that then perceived learning curve for the
technique is relatively steep in those centres that choose to
pursue this method of angioplasty and have published their
results. However, there was a high degree of between-
studies heterogeneity suggesting, particularly regarding
patency rates, that results vary widely between different
centres.
The limitations of this study principally lie within the
quality of the studies included in the analysis. All of the
papers were retrospective in nature and in the vast
majority the criteria used to select patients for SIA were
not given. In addition there was also a lack of conformity
to reporting data according to set standards (for example,
degree of ischaemia in patients undergoing SIA e vide
infra). This is probably due to the fact that patients
Table 5a Subgroup analyses for the outcome ‘technical success rate’ by lesion location
Lesion
location
n
Studies
n
Patients
Technical
success (%)
95% Confidence
interval (%)
Model
statistics
Technical success rate
All lesions 3 332 87.3 81.5e91.5 Heterogeneity: Tau2Z 0.00; Chi2Z 0.23, dfZ 2 (PZ 0.89);
I2Z 0%. Test for overall effect: ZZ 8.45 (P< 0.00001)
Iliac 2 79 88.4 63.4e97.1 Heterogeneity: Tau2Z 0.83; Chi2Z 3.43, dfZ 1 (PZ 0.06);
I2Z 71%. Test for overall effect: ZZ 2.69 (PZ 0.007)
Superficial femoral
artery
6 270 84.6 76.3e90.4 Heterogeneity: Tau2Z 0.32; Chi2Z 20.16, dfZ 5
(PZ 0.001); I2Z 75%. Test for overall effect:
ZZ 6.22 (P< 0.00001)
Femoro-popliteal 12 976 86.2 82.1e89.5 Heterogeneity: Tau2Z 0.14; Chi2Z 24.44, dfZ 11
(PZ 0.01); I2Z 55%. Test for overall effect: ZZ 11.53
(P< 0.00001)
Popliteo-tibial 2 70 82.4 75.3e87.7 Heterogeneity: Tau2Z 0.00; Chi2Z 0.96, dfZ 1 (PZ 0.33);
I2Z 0%. Test for overall effect: ZZ 7.11 (P< 0.00001)
Tibial 4 251 79.2 73.3e84.1 Heterogeneity: Tau2Z 0.00; Chi2Z 0.31, dfZ 3 (PZ 0.96);
I2Z 0%. Test for overall effect: ZZ 7.99 (P< 0.00001)
Infra-inguinal 9 832 84.9 77.9e89.9 Heterogeneity: Tau2Z 0.35; Chi2Z 35.65, dfZ 8
(P< 0.0001); I2Z 78%. Test for overall effect: ZZ 7.30
(P< 0.00001)
334 M.J. Bown et al.undergoing lower limb revascularization procedures are
a widely heterogenous group of patients and many of
these criteria (such as degree of ischaemia) are difficult to
define accurately. However, these limitations are recog-
nised in meta-analyses and providing the data is inter-
preted with these in mind the findings of this study are
valid.
There were no clear trends in any of the outcomes
analyzed when the studies were subdivided according to
either mode of presentation (degree of ischaemia),
adjunctive stent usage, selection criteria or lesion location.
However, these subgroups were defined according to the
data reported in each individual study. Few of the studiesTable 5b Subgroup analyses for the outcome ‘12-month prima
Lesion
location
n
Studies
n
Patients
12-Month
primary
patency (%)
95%
Confidence
interval (%)
Mo
12-Month primary patency
All lesions 3 174 59.4 50.5e67.6 He
I2
Iliac 2 79 61.2 38.7e80.0 He
I2
Superficial femoral
artery
3 188 46.8 21.3e74.0 He
I2
Femoro-popliteal 6 607 55.8 40.8e69.9 He
I2
Popliteo-tibial 1 50 55.9 40.5e70.4 n/
Tibial 2 72 48.7 38.3e59.5 He
I2
Infra-inguinal 2 233 66.2 35.1e87.8 He
I2used rigid definitions for any of these sub-classifications,
except for lesion location and in this case many authors
reported on mixed groups of lesions. This lack of structured
classification may have led to the fact that little difference
is seen in the outcomes for each subgroup. This is partic-
ularly clear in the case of the subgroups based on degree of
ischaemia. Tables 4ae4c demonstrates that it is difficult to
make the distinction between the modes of presentation in
the majority of studies and the outcomes from this
subgroup analysis, therefore, have to be interpreted with
caution.
In this study only primary patency data was extracted
from the studies in the analysis. Whilst data on primary-ry patency rate’ by lesion location
del statistics
terogeneity: Tau2Z 0.02; Chi2Z 2.50, dfZ 2 (PZ 0.29);
Z 20%. Test for overall effect: ZZ 2.09 (PZ 0.04)
terogeneity: Tau2Z 0.33; Chi2Z 3.93, dfZ 1 (PZ 0.05);
Z 75%. Test for overall effect: ZZ 0.97 (PZ 0.33)
terogeneity: Tau2Z 1.00; Chi2Z 27.95, dfZ 2 (P< 0.00001);
Z 93%. Test for overall effect: ZZ 0.22 (PZ 0.83)
terogeneity: Tau2Z 0.50; Chi2Z 56.14, dfZ 5 (P< 0.00001);
Z 91%. Test for overall effect: ZZ 0.76 (PZ 0.45)
a
terogeneity: Tau2Z 0.00; Chi2Z 0.38, dfZ 1 (PZ 0.54);
Z 0%. Test for overall effect: ZZ 0.23 (PZ 0.82)
terogeneity: Tau2Z 0.81; Chi2Z 13.69, dfZ 1 (PZ 0.0002);
Z 93% Test for overall effect: ZZ 1.02 (PZ 0.31)
Table 5c Subgroup analyses for the outcome ‘12-month limb salvage rate’ by lesion location
Lesion
location
n
Studies
n
Patients
12-Month
limb
salvage (%)
95%
Confidence
interval (%)
Model statistics
12-Month limb salvage rate
All lesions 3 227 88.7 63.1e97.3 Heterogeneity: Tau2Z 1.62; Chi2Z 17.81, dfZ 2 (PZ 0.0001);
I2Z 89%. Test for overall effect: ZZ 2.65 (PZ 0.008)
Superficial femoral
artery
2 140 97.7 93.1e99.3 Heterogeneity: Tau2Z 0.00; Chi2Z 0.43, dfZ 1 (PZ 0.51);
I2Z 0%. Test for overall effect: ZZ 6.42 (P< 0.00001)
Femoro-popliteal 3 311 89.8 85.9e92.7 Heterogeneity: Tau2Z 0.00; Chi2Z 0.93, dfZ 2 (PZ 0.63);
I2Z 0%. Test for overall effect: ZZ 11.51 (P< 0.00001)
Popliteo-tibial 2 70 85.2 78.5e90.1 Heterogeneity: Tau2Z 0.00; Chi2Z 0.83, dfZ 1 (PZ 0.36);
I2Z 0%. Test for overall effect: ZZ 7.53 (P< 0.00001)
Tibial 4 251 88.5 82.6e92.6 Heterogeneity: Tau2Z 0.00; Chi2Z 2.73, dfZ 3 (PZ 0.44);
I2Z 0%. Test for overall effect: ZZ 8.22 (P< 0.00001)
Infra-inguinal 4 323 88.2 75.3e94.9 Heterogeneity: Tau2Z 0.69; Chi2Z 17.57, dfZ 3 (PZ 0.0005);
I2Z 83%. Test for overall effect: ZZ 4.37 (P< 0.0001)
Subintimal Angioplasty e Meta-analysis 335assisted and secondary patency would also have been
useful to study but unfortunately very few studies quoted
this data (10 studies quoted primary-assisted patency at 5
different time points and 9 quoted secondary patency at
3 different time points). In the case of primary patency, 25
studies quoted this outcome and 19 of these quoted this at
12 months post-procedure and this was, therefore, deemed
the most useful data to extract.
Surgical bypass has been promoted as superior to
angioplasty in some interpretations of the BASIL trial,43
however, the results for SIA demonstrated in this study are
encouraging. In published series detailing outcomes
following lower limb bypass surgery primary patency rates
are marginally greater than those observed in this meta-
analysis and rates of limb salvage are all virtually identical
to those observed in this study.44e47
However, there was significant evidence of publication
bias for the two outcomes of technical success rate and
12-month limb salvage rate but not 12-month primary
patency rate. The analysis of funnel plots constructed for
technical success and 12-month limb salvage rates
revealed that the studies potentially missing from the
literature were those reporting poorer outcomes and uti-
lising these funnel plots to enhance the overall meta-
anlayses suggested that true rates are a few percent lower
than those quoted above. The fact that 12-month primary
patency did not demonstrate any evidence of publication
bias by this method of assessment suggests that these
studies with poorer outcomes are included in the reporting
for primary patency rates. The reasons for the potential
differences in reporting of these outcome measures are
difficult to ascertain from the data available in the pub-
lished literature.
The source publications used in this study were, in the
majority, retrospective case note reviews. Only just over
20% were prospective studies and no randomised controlled
studies have been published, although the reasons for this
are complex and it is unlikely that any large datasets will be
available in the near future. Because of the limited quality
strata represented in the dataset this led to difficulty inassessment of study quality effect on outcomes overall.
Non-English language publications were excluded from this
analysis. The inclusion of the data from these publications
would clearly have improved this study as a whole but the
costs of retrieval and translation could not be justified for
the relatively small contribution that they would have
made given the reasonably large number of studies in the
meta-analysis as a whole.
The clearest inference that can be made from this work
is that further research is required in this area if the place
of SIA in modern interventional radiology is to be better
defined and to attempt to explain the heterogeneity seen
between centres/studies. As mentioned above there are
no randomised controlled trials of SIA. The reasons for this
are manifold but are principally what technique to ran-
domise patients against and which patients to randomise.
The latter of these points could be relatively simply
answered with better descriptive studies of the types of
patients that undergo intervention (surgical, radiological
and medical) for peripheral vascular disease and their
relative outcomes in terms of limb salvage and quality
of life. This would require accurate and reproducible
assessments of the degree of ischaemia at the time of
treatment choice (rather than just anatomical patterns of
disease which would have to be included in this assess-
ment) to be able to stratify patients correctly. In terms of
what technique to compare SIA to this becomes even more
difficult. Clearly, a 50% mid-superficial femoral artery
stenosis is completely different from a full-length occlu-
sion and it would be impossible to randomise patients with
these two types of lesions to either transluminal angio-
plasty or SIA. However, it would be feasible to randomise
patients with long occlusions who were fit enough for
surgery to either SIA or lower limb bypass surgery which
would answer some of the issues raised by this paper.
Whether this is ethically responsible is questionable.
Those centres with expertise in SIA would argue that to
subject 50% of patients to the higher mortality risks of
surgery and the hospital to the higher costs of surgery
could not be justified.
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Figure 5 Funnel plots. Each point in the plot is an individual
study. The vertical line indicates the overall study estimate for
that outcome. The horizontal (dotted) line indicates the
manually fitted cut-off value to exclude outlying studies (those
below the line). (a) Immediate technical success, (b) 12-month
primary patency rate, and (c) 12-month limb salvage rate.
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